Infographics

South Africa launches national drive to eliminate schistosomiasis and intestinal wor...

Durban – In a major milestone for child health, South Africa has launched a nationwide initiative to eliminate two of the country’s most neglected tropical diseases (NTDs) — schistosomiasis (also known as bilharzia) and soil-transmitted helminths (intestinal worms) — with the support of the World Health Organization (WHO) and other key partners. Schistosomiasis, like soil-transmitted helminthiasis, rabies snake bites and leprosy, make up the four NTDs that are endemic in South Africa and are of public health concerns.

Protecting the future: annual review meeting of Ethiopia’s EPPR project

The Ethio-Pandemic Prevention, Preparedness and Response (EPPR) Project held its first Annual Review Meeting from 9 to 11 July 2025 in Bishoftu, Ethiopia. The review brought together high-level government officials, technical experts, UN representatives, and other partners committed to advancing Ethiopia’s pandemic preparedness through a unified One Health approach.

The youngest nation in Africa becomes the sixth Country to complete the 2nd generati...

Juba South Sudan faces recurring public health threats from infectious disease outbreaks to climate-related emergencies such as floods, drought and heat waves. As of August 2025, South Sudan had active outbreaks of Anthrax, Cholera, Circulating Vaccine Derived Polio Virus Type 2 (cVDPV2), Viral Hepatitis E, Measles and Mpox. At the same time, floods had inundated 16 health facilities and displaced more than 56,000 households with nearly 200,000 people.

South Sudan introduces the second dose of the Measles-Containing Vaccine (MCV2)

Juba South Sudan is taking a significant step forward in protecting its children from Measles with the nationwide introduction of the second dose of the Measles Containing Vaccine (MCV2) into the routine immunisation schedule. The two-dose regimen is part of the 2017 recommendations by the World Health Organisation to all countries. As of 12 August 2025, South Sudan will be the 45th country in the African Region to introduce MCV2.